Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Cilacar M 10mg/25mg Tablet
Manufacturer/Marketed By : JB CHEMICALS
$2.56 $2.17
Cilacar M 10 mg/25mg contains an active component such as Cilnidipine and metoprolol. Cilnidipine is a calcium channel blocker (CCB) that blocks calcium channels in blood vessels and the heart....
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
CILNIDIPINE,METOPROLOL
Active Pharmaceutical Ingredient
Cilacar M 10mg/25mg Tablet
2,56 $US
2,17 $US
Cilacar M 10 mg/25mg contains an active component such as Cilnidipine and metoprolol. Cilnidipine is a calcium channel blocker (CCB) that blocks calcium channels in blood vessels and the heart. It helps in lowering blood pressure. Metoprolol belongs to a class of medications known as beta-blockers. It decreases heart rate and reduces the force of contraction. This medication helps control high blood pressure and prevent angina, heart attack, and stroke. Using two medications with complementary mechanisms of action allows for lower doses of each drug, which may lead to a reduced risk of side effects commonly associated with higher doses of a single drug. By using lower doses, the likelihood of experiencing adverse effects may be diminished. Inform the doctor about any kidney or liver-related problems. If a patient is a breastfeeding mother or planning for pregnancy, they must inform the doctor before starting this medication. While using this medication, blood pressure should be monitored regularly, and a kidney function test should be performed to note if there are any abnormal changes. Individuals with known hypersensitivity or allergy to Cilacar M 10 mg/25mg or other components of these medications should not take them. This medication should be avoided or used with extreme caution in individuals with bradycardia (abnormally slow heart rate) or heart block and patients with heart failure, as this medication can affect cardiac function. In some cases, other medications may be preferred for managing hypertension in heart failure patients.
Active Pharmaceutical Ingredient
Uses
• Treatment of high blood pressure
• Helps in the prevention of angina
• Heart attack and stroke
Benefits
Cilacar M 10 mg/25mg tablets provide a synergistic therapeutic effect in managing hypertension. Cildipine, a calcium channel blocker, relaxes and dilates the blood vessels, reducing peripheral resistance and improving blood flow. Metoprolol, a beta blocker that reduces the heart rate and force of contraction, reduces the workload on the heart and further contributes to blood pressure reduction.
Side Effects
Cilacar M 10 mg/25mg tablets cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Sleepiness
• Fatigue
• Feeling warmth in face, neck, and ears
• Tiredness
• Feeling sleepy
• Headaches
• Back pain
• Stomach upset
• Nausea
• Muscle pain
Common Side Effects
• Irregular heartbeat
• Skin rash
• Hypotension
How To Use
Cilacar M 10 mg/25mg tablets can be administered orally in tablet form. The specific usage instructions may vary depending on the condition being treated and the form of the medication. Oral tablets are typically taken with water, as directed by the healthcare provider.
Safety Advice
• Breast Feeding: The safety of Cilacar M 10 mg/25mg tablets during breastfeeding has not been well studied, and limited information is available regarding its excretion into breast milk. As a result, it is recommended to exercise caution when using it while breastfeeding.
• Alcohol: Cilacar M 10 mg/25mg tablets with alcohol can increase the risk of certain side effects and adverse reactions. It is generally recommended to avoid or limit alcohol consumption while taking these medications.
• Liver: The Cilacar M 10 mg/25mg tablets should be used cautiously in individuals with liver impairment. Both medications are metabolized in the liver, and their clearance may be affected in patients with liver dysfunction. Reduced liver function can lead to a buildup of these drugs in the body, potentially increasing the risk of side effects or toxicity.
• Lungs: The Cilacar M 10 mg/25mg tablets should be used cautiously in individuals with certain lung conditions, such as asthma or chronic obstructive pulmonary disease (COPD).
• Driving: Cilacar M 10 mg/25mg tablets can cause side effects that may impair driving abilities in some individuals. Therefore, caution is advised when operating a vehicle or performing any tasks that require alertness and concentration while taking these medications.
• Pregnancy: The safety of Cilacar M 10 mg/25mg tablets during pregnancy has not been extensively studied, and limited information is available regarding its use in pregnant women. Therefore, the use of it during pregnancy should be carefully considered and evaluated by a healthcare professional, weighing the potential benefits against the potential risks.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.